Literature DB >> 3591312

In vitro susceptibility of Campylobacter pyloridis to cimetidine, sucralfate, bismuth and sixteen antibiotics.

J J Andreasen, L P Andersen.   

Abstract

The in vitro susceptibility of recent Danish human clinical isolates of Campylobacter pyloridis to cimetidine, sucralfate, bismuth subsalicylate and sixteen antimicrobial agents was determined by an agar-dilution technique. Benzylpenicillin was the most active drug (MIC90 = 0.1 microgram/ml); ampicillin, erythromycin, gentamicin and ciprofloxacin were slightly less active. All strains were resistant to 100 micrograms sulfamethizole, and nalidixic acid also had little activity on weight basis. Of the three anti-peptic ulcer drugs, bismuth subsalicylate was most active (MIC90 25 micrograms/ml), but sucralfate and cimetidine also had antibacterial activity, although only little (MIC90 3200 micrograms/ml).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3591312     DOI: 10.1111/j.1699-0463.1987.tb03103.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand B        ISSN: 0108-0180


  5 in total

1.  Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori.

Authors:  A E Simor; S Ferro; D E Low
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

Review 2.  Campylobacter pylori and gastroduodenal disease.

Authors:  G E Buck
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

Review 3.  A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.

Authors:  A Hackelsberger; P Malfertheiner
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

4.  Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time.

Authors:  S H Hartzen; L P Andersen; A Bremmelgaard; H Colding; M Arpi; J Kristiansen; T Justesen; F Espersen; N Frimodt-Møller; O Bonnevie
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

5.  Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents.

Authors:  Y Glupczynski; M Delmee; C Bruck; M Labbe; V Avesani; A Burette
Journal:  Eur J Epidemiol       Date:  1988-06       Impact factor: 8.082

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.